These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33723390)

  • 1. A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
    Halle MK; Sødal M; Forsse D; Engerud H; Woie K; Lura NG; Wagner-Larsen KS; Trovik J; Bertelsen BI; Haldorsen IS; Ojesina AI; Krakstad C
    Br J Cancer; 2021 May; 124(10):1690-1698. PubMed ID: 33723390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome.
    Alifu M; Fan P; Kuerban G; Yao X; Peng Y; Dong T; Wang R
    Arch Gynecol Obstet; 2018 Mar; 297(3):757-766. PubMed ID: 29356954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
    Qin R; Cao L; Ye C; Wang J; Sun Z
    BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.
    Hu JM; Sun Q; Li L; Liu CX; Chen YZ; Zou H; Pang LJ; Zhao J; Yang L; Cao YW; Cui XB; Qi Y; Liang WH; Zhang WJ; Li F
    Int J Clin Exp Pathol; 2014; 7(9):6165-71. PubMed ID: 25337265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II susceptibility to cervical cancer among Tunisian women.
    Ben Othmane Y; Ghazouani E; Mezlini A; Lagha A; Raïs M; Kochkar R; Zidi S; Afrit M; Mota-Vieira L; Yacoubi Loueslati B
    Bull Cancer; 2012 Sep; 99(9):81-6. PubMed ID: 22863772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HLA-DQB1 gene polymorphisms associated with cervical cancer risk: A meta-analysis.
    Zhang X; Lv Z; Yu H; Wang F; Zhu J
    Biomed Pharmacother; 2015 Jul; 73():58-64. PubMed ID: 26211583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
    Halle MK; Ojesina AI; Engerud H; Woie K; Tangen IL; Holst F; Høivik E; Kusonmano K; Haldorsen IS; Vintermyr OK; Trovik J; Bertelsen BI; Salvesen HB; Krakstad C
    Am J Obstet Gynecol; 2017 Oct; 217(4):432.e1-432.e17. PubMed ID: 28599900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA-DQB1 allele polymorphisms in Uyghur women with cervical cancer.
    Han L; Husaiyin S; Wang L; Wusainahong KD; Fu X; Niyazi M
    Genet Mol Res; 2015 Dec; 14(4):17252-61. PubMed ID: 26681219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DRB1 and DQB1 HLA class II polymorphisms in high-grade and neoplastic cervical lesions of women from Argentina.
    Eiguchi K; Tatti S; Alonio LV; González JV; Leirós GJ; Fleider L; Vighi S; Padros K; Raimondi E; Teyssié A; Picconi MA
    J Low Genit Tract Dis; 2008 Oct; 12(4):262-8. PubMed ID: 18820539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of HLA-DRB1 and -DQB1 alleles in cervical cancer cases in the Czech Republic.
    Hamsíková E; Srámková I; Loudová M; Ludvíková V; Rob L; Vonka V
    Folia Biol (Praha); 1999; 45(1):31-4. PubMed ID: 10732716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
    Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective association of HLA-DRB1*13:02, HLA-DRB1*04:06, and HLA-DQB1*06:04 alleles with cervical cancer in a Korean population.
    Shim H; Park B; Shin HJ; Joo J; Yoon KA; Kim YM; Hayashi T; Tokunaga K; Kong SY; Kim JY
    Hum Immunol; 2019 Feb; 80(2):107-111. PubMed ID: 30352277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
    J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
    Qu X; Shi Z; Guo J; Guo C; Qiu J; Hua K
    Cancer Med; 2021 Oct; 10(19):6881-6896. PubMed ID: 34498424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.